93 related articles for article (PubMed ID: 8535955)
1. Corneal vascularization and opacification during long-term use of dipivefrin.
Salminen L; Krootila K; Helin H; Hakala T
J Ocul Pharmacol Ther; 1995; 11(1):37-40. PubMed ID: 8535955
[TBL] [Abstract][Full Text] [Related]
2. Bulbar conjunctival follicles associated with dipivefrin therapy.
Liesegang TJ
Ophthalmology; 1985 Feb; 92(2):228-33. PubMed ID: 3982802
[TBL] [Abstract][Full Text] [Related]
3. [Experiences with the effectiveness and tolerance of guanethidine/dipivefrin-AT in the treatment of increased intraocular pressure].
Ober M; Scharrer A
Klin Monbl Augenheilkd; 1986 Jan; 188(1):64-6. PubMed ID: 3959479
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic index of epinephrine and dipivefrin with nasolacrimal occlusion.
Zimmerman TJ; Sharir M; Nardin GF; Fuqua M
Am J Ophthalmol; 1992 Jul; 114(1):8-13. PubMed ID: 1621789
[TBL] [Abstract][Full Text] [Related]
5. [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure].
Ober M; Scharrer A; Dausch D
Klin Monbl Augenheilkd; 1987 Feb; 190(2):103-4. PubMed ID: 3573660
[TBL] [Abstract][Full Text] [Related]
6. A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution.
Tsujinaka A; Takai Y; Inoue Y; Tanito M
Acta Ophthalmol; 2019 Sep; 97(6):e948-e949. PubMed ID: 30609169
[No Abstract] [Full Text] [Related]
7. Dipivefrin and epinephrine treatment of elevated intraocular pressure: a comparative study.
Kass MA; Mandell AI; Goldberg I; Paine JM; Becker B
Arch Ophthalmol; 1979 Oct; 97(10):1865-6. PubMed ID: 39539
[TBL] [Abstract][Full Text] [Related]
8. Corneal sterile infiltration induced by topical use of ocular hypotensive agent.
Manabe Y; Sawada A; Mochizuki K
Eur J Ophthalmol; 2020 Sep; 30(5):NP23-NP25. PubMed ID: 31096781
[TBL] [Abstract][Full Text] [Related]
9. A correlation between latanoprost-induced conjunctival hyperemia and intraocular pressure-lowering effect.
Kobayashi H; Kobayashi K
J Glaucoma; 2011 Jan; 20(1):3-6. PubMed ID: 20520573
[TBL] [Abstract][Full Text] [Related]
10. Effect of adding betaxolol to dipivefrin therapy.
Weinreb RN; Ritch R; Kushner FH
Am J Ophthalmol; 1986 Feb; 101(2):196-8. PubMed ID: 3946535
[TBL] [Abstract][Full Text] [Related]
11. An advance in ophthalmic pharmacology. The use of the epinephrine pro-drug dipivalyl epinephrine in the treatment of glaucoma.
Garzia R
J Am Optom Assoc; 1982 Sep; 53(9):727-30. PubMed ID: 7130613
[TBL] [Abstract][Full Text] [Related]
12. Follicular conjunctivitis on Dipivefrin therapy for glaucoma.
Coleiro JA; Sigurdsson H; Lockyer JA
Eye (Lond); 1988; 2 ( Pt 4)():440-2. PubMed ID: 3253137
[TBL] [Abstract][Full Text] [Related]
13. Restoring sensitivity to timolol after long-term drift in primary open-angle glaucoma.
Gandolfi SA
Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):354-8. PubMed ID: 2406218
[TBL] [Abstract][Full Text] [Related]
14. [The additive effect of dipivefrin in patients with wide angle glaucoma treated with long-term beta-blocker therapy in comparison with clonidine].
Alimgil ML; Erda S; Benian O
Klin Monbl Augenheilkd; 1994 Aug; 205(2):114-6. PubMed ID: 7967405
[No Abstract] [Full Text] [Related]
15. [Therapy of primary open-angle glaucoma by oftan-dipivefrin].
Egorov EA; Alekseev VN; Erichev VP; Usachev VV; Simonova SV; Iakubova LV
Vestn Oftalmol; 2000; 116(1):32-3. PubMed ID: 10741262
[TBL] [Abstract][Full Text] [Related]
16. Dipivefrin: current concepts.
Goldberg I; Kolker AE; Kass MA; Becker B
Aust J Ophthalmol; 1980 May; 8(2):147-50. PubMed ID: 7004425
[TBL] [Abstract][Full Text] [Related]
17. Levobunolol compared to dipivefrin in African American patients with open angle glaucoma.
Drake MV; Wilson MR; Harris D; Goodwin L
J Ocul Pharmacol; 1993; 9(2):91-5. PubMed ID: 8123096
[TBL] [Abstract][Full Text] [Related]
18. Pilocarpine and dipivefrin.
Cantor LB
CLAO J; 1991 Apr; 17(2):134. PubMed ID: 2049823
[No Abstract] [Full Text] [Related]
19. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
Gandolfi SA; Vecchi M
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
[TBL] [Abstract][Full Text] [Related]
20. [Dipivefrin: its mechanism of action, clinical efficacy and good tolerance].
Harper DG; Novack GD; Borrmann LR; Branin MJ
Ophtalmologie; 1989; 3(4):306-7. PubMed ID: 2641142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
